Dr. Harris is a general surgeon with an active clinical practice, over two decades of extramural research funding, broad administrative leadership experience and a focused interest on acute injury and tissue repair. For more than 25 years, he actively investigated triglyceride-rich lipoproteins and apolipoproteins as integral components of the host immune response to infection and acute injury. However, approximately eight years ago, he made the deliberate decision to transition his research activities from the basic science investigation of sepsis to translational projects focused on common surgical conditions (e.g., treatment and prevention of incisional hernias, chronic wounds and surgical site infections). The transition has been both exciting and challenging, including the need to broaden his sources of research support. As such, he is an established clinician-scientist with a robust clinical practice and a growing translational research program. Furthermore, he has served on numerous scientific review committees, including the NIH Director’s Pioneer Awards, NIH Director’s New Innovators Awards, Chair of the Surgery, Anesthesiology and Trauma Study Section at CSR/NIH, and Chair of the Research Advisory Board, Shriners Hospitals for Children. At present, he remains dedicated to identifying creative strategies to improve the care of patients, and considers it a genuine privilege to care for patients, train future physicians and surgeons, and work to bring unique observations from the lab bench to the clinic and patient’s bedside.